HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: Bortezomib Concurrent Therapy Criteria

Read the concurrent therapy criteria about a current clinical trial being conducted to study the effects of Bortezomib for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the clinical trials are not being conducted in the United States.

Prior Concurrent Therapy:
• No prior Bortezomib
• No prior extensive radiation therapy, systemic chemotherapy, or other antineoplastic therapy within 4 weeks before enrollment
• No preplanned surgery or procedures that would interfere with the study
• More than 4 weeks since enrollment in another therapeutic clinical trial (i.e., received an experimental drug or used an experimental medical device)
o Concurrent participation in non-treatment studies is allowed provided they do not interfere with participation in this study
• No concurrent experimental or antineoplastic agent other than Bortezomib
o Medications that may have antineoplastic activity, but are taken for other reasons than specific antineoplastic effect (e.g., megestrol [Megace®], cyclo-oxygenase-2 [COX-2] inhibitors, or bisphosphonates) are allowed

Courtesy of ClinicalTrials.gov,

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


Mesothelioma
Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma
IN THIS SECTION
Bortezomib trial description for mesothelioma
Bortezomib and Cisplatin in mesothelioma trial
Outcomes of Bortezomib against mesothelioma cancer
Mesothelioma: Bortezomib Criteria
Effects of Bortezomib trial on mesothelioma cancer
Bortezomib therapy for mesothelioma patients
Bortezomib therapy for mesothelioma patients
Bortezomib and Cisplatin in mesothelioma trial

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Effects of Bortezomib trial on mesothelioma cancer Clinical trial to study effects of Bortezomib on mesothelioma patients
The effects of Bortezomib clinical trial on mesothelioma patients

Bortezomib therapy for mesothelioma patients Therapy program to treat mesothelioma patients with Bortezomib
Read about Bortezomib therapy program for mesothelioma patients

Current Bortezomib therapy for mesothelioma Current clinical trial of Bortezomib therapy for mesothelioma patients
Bortezomib may inhibit cancer cell growth in current mesothelioma test